Biopharma / Medtech Reports

January 29, 2025

RFK Risks Post-Confirmation Hearing

•

John Leppard

BRKR (US), CNC (US), CVS (US), GSK (LSE), ILMN (US), MOH (US), NVO (US), SNY (US)
January 21, 2025

Guardant (GH) Reveal Medicare Coverage FAQ

•

John Leppard

GH (US)
January 17, 2025

[NVO, BHC, TEVA] Quantifying IRA Price Negotiation Risks

•

John Leppard

ABBV (US), AMGN (US), BHC (US), BMY (US), GSK (US), LLY (US), NVO (US), TEVA (TA)
January 13, 2025

Medtronic: Medicare RDN Coverage in 4Q24

•

John Leppard

MDT (US)
January 13, 2025

Inspire V Payment & Coverage Quick Take

•

John Leppard

INSP (US)
January 12, 2025

Diagnostics’ New Supreme Court Risk

•

John Leppard

EXAS (US), GH (US), HOLX (US), MYGN (US), NEO (US), OSUR (US)
January 10, 2025

Medtronic (MDT): Renal Denervation Coverage Read-Through?

•

John Leppard

MDT (US)
January 8, 2025

Exact Sciences (EXAS): Cologuard Plus Coverage Questions

•

John Leppard

EXAS (US)
January 6, 2025

Conference Policy Prep Pack: Devices, Diagnostics, & Tools

•

John Leppard

BSX (US), DXCM (US), EW (US), EXAS (US), GH (US), GKOS (US), INSP (US), MDT (US)
December 20, 2024

EW: Tricuspid Coverage Positive, With Some Caveats

•

John Leppard

ABT (US), EW (US)